Resistance Training in Patients With Morbid Obesity
ExinMO
Preventing Metabolic Syndrome in Patients With Morbid Obesity by Resistance Training: Reporting Non-responder Prevalence
1 other identifier
interventional
39
1 country
1
Brief Summary
The researchers will conduct a study for avoiding the metabolic syndrome in morbid obese patients. Thus, the aim of the present will be determine the effects of a resistance training programme (RT) in preventing or attenuating metabolic syndrome (MetS) in patients with morbid obesity. A second aim will be report the prevalence of non-responders in terms of improvements in MetS markers and other co-variables considered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2018
CompletedFirst Submitted
Initial submission to the registry
April 8, 2019
CompletedFirst Posted
Study publicly available on registry
April 19, 2019
CompletedApril 19, 2019
April 1, 2019
3 months
April 8, 2019
April 16, 2019
Conditions
Outcome Measures
Primary Outcomes (5)
Fasting glucose
Component of the Metabolic Syndrome
Change from Baseline Fasting glucose at 20-weeks of Resistant Training
High density lipoprotein
Component of the Metabolic Syndrome
Change from Baseline High density lipoprotein at 20-weeks of Resistant Training
Systolic blood pressure and diastolic blood pressure
Component of the Metabolic Syndrome
from Baseline Systolic blood pressure and diastolic blood after 20-weeks of Resistant Training
Waist circumference
Component of the Metabolic Syndrome
Change from Baseline Waist circumference at 20-weeks of Resistant Training
Triglycerides
Component of the Metabolic Syndrome
Change from Baseline Triglycerides at 20-weeks of Resistant Training
Secondary Outcomes (7)
Body mass index
Change from Baseline Body mass index at 20-weeks of Resistant Training
Body mass
Change from Baseline Body mass at 20-weeks of Resistant Training
Total cholesterol
Change from Baseline Total cholesterol at 20-weeks of Resistant Training
Low density lipoprotein
Change from Baseline Low density lipoprotein at 20-weeks of Resistant Training
Six minutes walking test
Change from Baseline Six minutes walking test density lipoprotein at 20-weeks of Resistant Training
- +2 more secondary outcomes
Study Arms (2)
Active comparator
ACTIVE COMPARATORControl group with obesity under Resistant Training
Experimental group with morbid obesity
EXPERIMENTALExperimental group with morbid obesity under Resistant Training
Interventions
The 20-week RT program will consist of three sessions per week, each lasting for 1 hour that will be applied to both control obese (CG) and morbid obese (MO) group. All sessions will start with 15 minutes warm-up with continuous walking and joint mobility and flexibility exercises, 5 minutes of cool down and stretching, in order for preventing injuries. Sessions will include 4 to 8 RT exercises targeting different muscle groups; 1. forearm, 2. knee flexors and 3. extensors, 3. trunk, 4. chest, 5. shoulder elevators, 6. horizontal shoulder flexors and 7. extensors, and 8. plantar flexors. The exercises for each muscle group will be performed in 3 sets of as many repetitions (continuous concentric/eccentric voluntary contraction) possible in 1 minute followed by 2.0 minutes of passive recovery. Before the RT program, each participant will be measure using the subjective modified Borg scale (1-10 points), in order of identifying the muscle failure into 1 minute of exercise.
Eligibility Criteria
You may qualify if:
- Older than 18 and younger and ≤65 years of age.
- With risk factors to Metabolic syndrome
- With obesity and morbid obesity condition
- Medical authorization by a physician.
You may not qualify if:
- Physical limitations (e.g., restricting injuries of the musculoskeletal system, or dependent of a third person).
- Exercise-related dyspnoea or respiratory alterations.
- Chronic heart disease with any worsening in the last month.
- Adherence rate of less than 80% of the total interventions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad de Los Lagoslead
- Universidad de La Fronteracollaborator
Study Sites (1)
Cristian ALvarez
Osorno, Llanquihue, 5290000, Chile
Related Publications (1)
Delgado-Floody P, Alvarez C, Lusa Cadore E, Flores-Opazo M, Caamano-Navarrete F, Izquierdo M. Preventing metabolic syndrome in morbid obesity with resistance training: Reporting interindividual variability. Nutr Metab Cardiovasc Dis. 2019 Dec;29(12):1368-1381. doi: 10.1016/j.numecd.2019.07.002. Epub 2019 Jul 12.
PMID: 31383503DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Cristian ALvarez, PhD
Universidad de Los Lagos
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- According with the availability and the feasibility of the enrolment's requirements, patients will be allocated to a control group with obesity, and another with morbid obesity.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 8, 2019
First Posted
April 19, 2019
Study Start
January 1, 2018
Primary Completion
April 4, 2018
Study Completion
April 30, 2018
Last Updated
April 19, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share
The participants information will be available by e-mail according with researchers requirements.